Transdermal Drug Delivery System [TDDS]
-
Upload
sagar-savale -
Category
Health & Medicine
-
view
571 -
download
8
Transcript of Transdermal Drug Delivery System [TDDS]
Transdermal Drug Delivery System [TDDS]
05/01/23SAGAR KISHOR SAVALE1
Contents:-
Introduction to TDDS’s
Basic Components of TDDS’s
Factors of TDDS
Penetration Enhancements
Percutaneous Absorption
Approaches used in TDDS’s
Production of TDDS’s
Model Drug Selection Criteria
Evaluation of TDDS05/01/23SAGAR KISHOR SAVALE2
A] Introduction to TDDS’s-Management of illness through medication has entered an era of rapid growth. A variety of means by which drugs are delivered to the human body for the therapy such as tablets, capsules, injections, aerosols, creams, ointments, suppositories, liquids etc. are referred as a conventional drug formulations.
Among many pharmaceutical dosage forms, continuous intravenous infusion at preprogrammed rate has been recognized as a superior mode of drug delivery.
At present, the most common form of delivery of drugs is the oral route. It has the notable advantage of easy administration.
Contd...
05/01/23SAGAR KISHOR SAVALE3
But these delivery systems having some Drawbacks-Oral- poor bioavailability hepatic metabolism (first pass) tendency to produce rapid blood level spikes need of high and/or frequent dosing
Intravenous- These mode of drug delivery entails certain risks and therefore necessities hospitalization of the patients and close medical supervision of the medication.
To overcome these difficulties there is a need for the development of new drug delivery system which will improve the therapeutic efficacy and safety of drugs by more precisely.
Contd...
05/01/23SAGAR KISHOR SAVALE4
The integument as an organ The integument as an organ,
and is an alternative name for skin.
The integumentary system includes the skin and the skin derivatives hair, nails, and glands.
05/01/23SAGAR KISHOR SAVALE5
The Integument Is the largest system of the body
16% of body weight, 1.5 to 2m2 in area, The integument is made up of two parts:
1. Cutaneous membranea. Epidermis– Superficial epitheliumb. Dermis – underlying CT with blood supply
2. Accessory structuresa. Hairb. Nailsc. Exocrine Glands
05/01/23SAGAR KISHOR SAVALE6
Protection First line of defense against
Bacteria Viruses
Protects underlying structures from Ultraviolet (UV) radiation Dehydration
Vitamin D production Needed for calcium absorption
Sensation Sensory receptors
05/01/23SAGAR KISHOR SAVALE7
Body temperature regulationIf too hot
Dermal blood vessels dilate Vessels carry more blood to surface so heat can escape
If too cold Dermal blood vessels constrict Prevents heat from escaping
ExcretionSmall amounts of waste products are lost
through perspiration
05/01/23SAGAR KISHOR SAVALE8
Understanding how the skin can function in these many ways starts with understanding the structure of the 3 layers of skin
The Epidermis Epithelial tissue
Dermis Dense connective tissue proper – irregular
Hypodermis Subcutaneous tissue- loose connective tissue
proper and adipose tissue
05/01/23SAGAR KISHOR SAVALE9
05/01/23SAGAR KISHOR SAVALE10
05/01/23SAGAR KISHOR SAVALE11
05/01/23SAGAR KISHOR SAVALE12
Epidermis
Dermis
Hypodermis or
subcutaneous layer
05/01/23SAGAR KISHOR SAVALE13
The Epidermis Is a vascular stratified squamous epithelium
Nutrients and oxygen diffuse from capillaries in the dermis
Cells of the EpidermisKeratinocytes
Contain large amounts of keratinAre the most abundant cells in the epidermis
05/01/23SAGAR KISHOR SAVALE14
05/01/23SAGAR KISHOR SAVALE15
The structural relationship andinterface between the epidermisand underlying dermis. Theproportions of the various layersdiffer with the location sampled.
Dermis
Epidermis
Epidermalridge
Dermalpapilla
05/01/23SAGAR KISHOR SAVALE16
Thin SkinCovers most of the body Has four layers of keratinocytes
Thick SkinCovers the palms of the hands and soles of
the feetHas five layers of keratinocytes
05/01/23SAGAR KISHOR SAVALE17
Structures of the Epidermis The five strata of keratinocytes in thick
skin From basal lamina to free surface
1. Stratum basale2. Stratum spinosum3. Stratum granulosum4. Stratum lucidum5. Stratum corneum
05/01/23SAGAR KISHOR SAVALE18
Thick skin LM 210
Surface
Stratumcorneum
Stratumlucidum
Stratumgranulosum
StratumspinosumStratum basaleBasementmembrane
DermisPapillary layer of dermis
05/01/23SAGAR KISHOR SAVALE19
Stratum BasaleIs attached to basement membrane by
hemidesmosomesForms a strong bond between epidermis and
dermisForms epidermal ridges (e.g., fingerprints) Dermal papillae (tiny mounds)
Increase the area of basement membraneStrengthen attachment between epidermis and dermis
Has many basal cells or germinative cells
05/01/23SAGAR KISHOR SAVALE20
Thick skin SEM 25
Epidermalridge
Pores of sweatgland ducts
Epidermal ridges
05/01/23SAGAR KISHOR SAVALE21
Stratum Spinosum — the “spiny layer”Produced by division of stratum basaleEight to ten layers of keratinocytes bound by
desmosomesCells shrink until cytoskeletons stick out (spiny)Continue to divide, increasing thickness of
epitheliumContain dendritic (Langerhans) cells, active in
immune response 05/01/23SAGAR KISHOR SAVALE22
Stratum Granulosum — the “grainy layer” Stops dividing, starts producing
Keratin A tough, fibrous protein Makes up hair and nails
Keratohyalin Dense granulesCross-link keratin fibers
05/01/23SAGAR KISHOR SAVALE23
Stratum Lucidum — the “clear layer”Found only in thick skinCovers stratum granulosum
Stratum Corneum — the “horn layer”Exposed surface of skin 15 to 30 layers of keratinized cellsWater resistantShed and replaced every 2 weeks
05/01/23SAGAR KISHOR SAVALE24
The Dermis Located between
epidermis and subcutaneous layer
Anchors epidermal accessory structures (hair follicles, sweat glands)
Two components1. Outer papillary layer 2. Deep reticular layer
Der
mis
05/01/23SAGAR KISHOR SAVALE25
The Papillary LayerConsists of areolar tissueContains smaller capillaries, lymphatics, and
sensory neuronsHas dermal papillae projecting between
epidermal ridgesThe Reticular Layer
Consists of dense irregular connective tissueContains larger blood vessels, lymphatic
vessels, and nerve fibersContains collagen and elastic fibersContains connective tissue proper 05/01/23SAGAR KISHOR SAVALE26
An inflammation of the papillary layerCaused by
infection, radiation, mechanical irritation, or chemicals (e.g., poison ivy)
Characterized by itch or pain
CharacteristicsStrong, due to collagen fibersElastic, due to elastic fibersFlexible
05/01/23SAGAR KISHOR SAVALE27
Hair
Papillarylayer
Reticularlayer
Cutaneousplexus
Papillaryplexus
Epidermalridges
Dermalpapillae
Capillary loopof papillary
plexus
05/01/23SAGAR KISHOR SAVALE28
The Hypodermis (Subcutaneous Layer)Lies below the integumentStabilizes the skinAllows separate movement Made of elastic areolar and adipose tissuesConnected to the reticular layer of integument
by connective tissue fibersDeposits of Subcutaneous Fat
Distribution patterns determined by hormones
Reduced by cosmetic liposuction (lipoplasty)
05/01/23SAGAR KISHOR SAVALE29
05/01/23SAGAR KISHOR SAVALE30
Transdermal Drug Delivery System
Contd...
05/01/23SAGAR KISHOR SAVALE31
One of the methods most often utilized has been transdermal delivery - meaning transport of therapeutic substances through the skin for systemic effect in the form of patches that deliver drugs for systemic effects at a predetermined and controlled rate.
Definition- When the aim is to deliver drugs through skin in a predetermined & controlled release fashion, it is known transdermal drug delivery system.
It is a polymeric drug delivery system which contains drug either in a reservoir with a rate – controlling membrane or dispersed in polymer matrix.
Contd...
05/01/23SAGAR KISHOR SAVALE32
Comparison between IV, Oral and TDDs:-I V Oral TDD
Reduced Liver First pass effect
Yes No Yes
Constant Drug Levels
Yes No Yes
Self-administration
No Yes Yes
Unrestricted Patient Activity
No Yes Yes
Non-invasive No Yes Yes
Contd...
05/01/23SAGAR KISHOR SAVALE33
Advantages of Transdermal system:-
Dosage intervals not limited by gastric transit time.Avoid the first- pass effect.Noninvasive.Allows effective use of drug with short biological half- life.Drugs with narrow therapeutic indices can be safely administered. Drug therapy may be terminated rapidly by removal of the application from the surface of the skin.Self administration is possible.Single application has capacity for multi-day therapy, thereby improving patient compliance.Easy to prepare and easy to transport.
Contd...
05/01/23SAGAR KISHOR SAVALE34
Disadvantages of Transdermal system:-
Only potent drugs are suitable Candidate.Unsuitable for drugs that irritate or sensitize the skin.These systems include variation in absorption efficiency at different sites of skinMaintaining contact between device & skin can be problem.Barrier function of skin changes from one site to another on same person, from person to person & with age.Some Patients develop contact dermatitis at the site of application.
Contd...
05/01/23SAGAR KISHOR SAVALE35
These Route is Unsuitable when:-
Drug dose is large. Drug has large molecular size. Drug is skin sensitizing and irritating. Drug is highly lipophilic or hydrophilic.
05/01/23SAGAR KISHOR SAVALE36
B] Basic Components Of Transdermal System:-
Polymer matrix / Drug reservoirDrugPenetration enhancersPressure sensitive adhesive (PSA)Backing laminatesRelease linerOther excipients like plasticizers and solvents
05/01/23SAGAR KISHOR SAVALE37
Polymer matrix / Drug reservoir:-
Control the release of the drug. Prepared by dispersion. Should have biocompatibility and chemical compatibility.
Natural Polymer Synthetic Elastomer Synthetic Polymer
Gelatin Neoprene Polyethylene
Gum Arabic Silicone rubber Polystyrene
Starch Butyl rubber PVC
Shellac Chloroprene PVP
zein Polysiloxane Polyster
Contd...
05/01/23SAGAR KISHOR SAVALE38
Drug:-
The foremost requirement of TDDS is that the drug possesses the right mix of physicochemical and biological properties.Biological properties-
Therapeutic IndexBiological half lifeSkin toxicity
Physicochemical properties-Mol. WtPartition coefficientDrug stabilityMelting point
Contd...
05/01/23SAGAR KISHOR SAVALE39
Penetration Enhancers:-Two types of principles have been employed to increase drug permeation (and drug absorption) through skin: chemical and physical.
Chemical enhancers-Substance exist which temporarily diminish the
impermeability of the skin, known also as accelerants or sorption promoters.Examples-Sulphoxides and similar chemicals, Azone, Pyrrolidones, Fatty acids, Essential oils, terpenes, terpenoids, Oxazolidodienes and Urea.
Physical enhancers- Physical enhancement technologies have taken off
where the limitations of chemical enhancement have been reached. Methodologies involved in the physical transdermal delivery including: •Electrically-based techniques: iontophoresis, electroporation, ultrasound, photomechanical wave,•Structure-based techniques: microneedles, and •Velocity-based techniques: jet-propulsion
Contd...
05/01/23SAGAR KISHOR SAVALE40
Pressure Sensitive Adhesives (PSA):-
A PSA is a material that helps in maintaining an intimate contact between transdermal system and the skin surface.It can be positioned on the face of the deviceSome widely used pressure sensitive adhesives are-
PolyisobutylenePolyacrylatesSilicones
Contd...
1505/01/23SAGAR KISHOR SAVALE41
Backing Laminate:-Hold and protect the drug reservoir from exposure to atmosphere.Avoid loss of drugAccept printing High flexibilityGood oxygen transmission and a high moisture vapor transmission rateExamples- vinyl, polyethylene and polyester films.
Release Liner:-During storage the patch is covered by a protective liner that is removed and discharged immediately before the application of the patch to skin. Part of primary packagingBase layer -Non-occlusive (e.g. paper fabric) or occlusive (e.g. polyethylene, polyvinylchloride).Release coating layer- silicon or Teflon.
Contd...
05/01/23SAGAR KISHOR SAVALE42
Other Excipients:-Various solvents used to prepare drug reservoirEx- chloroform, methanol, acetone, isopropanol and dichloromethane.
Plasticizers are also added to provide plasticity to the transdermal patch.Ex- dibutylpthalate, triethylcitrate, polyethylene glycol and propylene glycol
05/01/23SAGAR KISHOR SAVALE43
05/01/23SAGAR KISHOR SAVALE44
Factors affecting Transdermal permeation
05/01/23SAGAR KISHOR SAVALE45
C] Penetration Enhancement:-Skin structure as it relates to drug penetration:-
The skin is a multilayered organ, complex in structure and function. It is composed of-Outer epidermis (outermost layered called STRATUM CORNEUM)Viable epidermis (stratum lucidum, stratum granulosum, stratum spinosum and stratum germinotive)Dermis
Contd...
05/01/23SAGAR KISHOR SAVALE46
Enhancers:-Three pathways for drug penetration through the skin-Polar (cause protein conformational change or solvent swelling).Non-polar (alter the rigidity of lipid structure which substantially increase diffusion).Polar/non-polar (altering the multilaminated pathway for penetrants).
Contd...
05/01/23SAGAR KISHOR SAVALE47
05/01/23SAGAR KISHOR SAVALE48
Classification Of Penetration Enhancement
Chemical
Physical
1. Sulphoxides and similar chemicals
2. Azone3. Pyrrolidones4. Fatty acids5. Essential oils,
terpenes and terpenoids
6. Oxazolidodienes7. Urea
A] Electrically based techniques-1. Iontophoresis2. Electroporation3. Ultrasound (sonophoresis)4. Photochemical waves5. Laser Ablation6. Combination of electrically based physical enhancement technique and chemical enhancers. B] Structured based technique-1. Micro needles C] Velocity based technique-1. Jet-propelled particles
Contd...
05/01/23SAGAR KISHOR SAVALE49
Chemical Penetration Enhancement:-
Ideal characteristics of chemical penetration enhancers
Non-toxic, non-irritating and non-allergenicThe activity and duration of effect should be both predictable and reproducible.No pharmacological activity within the body.UnidirectionalBarrier properties should return to normal.Cosmetically acceptable with an appropriate skin feel.
Mechanism of chemical penetration enhancement:- Disruption of the highly ordered structure of stratum corneum lipid.Interaction with intercellular protein.Improved partition of the drug, co enhancer or solvent into the stratum corneum.
05/01/23SAGAR KISHOR SAVALE50
1. Sulphoxides and similar chemicals:-
Aprotic solvent, colourless, odourless and hydroscopic It is known as ‘Universal Solvent’ for TDDs. The effect is concentration-dependant (›60% ) Cause erythema, denaturing of skin, burning sensation. Ex- showing a 12-fold increase in the flux of caffeine
permeating across a DMF-treated human skin, but it also shows irreversible damage to skin.
2. Azone:-
Azone (1-dodecylazacycloheptan-2-one or laurocapran) Colourless, odourless liquid with a melting point of -7 ºC Smooth, oily but yet non-greasyfeel. Soluble in most of organic solvent. Effect showing in 0.1-5% (more often between 1-3%)
Contd...
05/01/23SAGAR KISHOR SAVALE51
3. Pyrrolidones:-
Used as permeation enhancers for numerous molecules including hydrophilic (e.g. mannitol and 5-flurouracil) and lipophilic (progesterone and hydrocortisone) permeants.Ex-N-methyl-2 pyrolidone was employed with limited success as a penetration enhancer for captopril when formulated in a matrix-type transdermal patch.
4. Fatty acids:-
Percutaneous absorption can be increased by long-chain fatty acids such as oleic acid.Ex- Oleic acid increase the flux 28 fold of salicylic acid and 56 of 5-flourouracil.
5. Essential oils, terpenes and terpenoids:-
It is used as medicinal use as well as flavoring agent and fragrance agent.Ex- Chenopodium found to be effective penetration enhancers for 5-flouorouracil transversing human skin.
Contd...
05/01/23SAGAR KISHOR SAVALE52
6. Oxazolidinones:-
Potential for use in many cosmetic and personal care product formulations.It having ability to localize co-administered drug in skin layers, resulting in low systemic permeation.Ex- 4-decyloxazolidin-2-one -localize the delivery of retinoic acid and diclofenac sodium in skin layers.
7. Urea
Cyclic urea permeation enhancers are biodegradable and non-toxic molecules.Enhancement mechanism by lipid disruption mechanism.
05/01/23SAGAR KISHOR SAVALE53
Physical Penetration Enhancement:-1. Iontophoresis:-
It acts by repulsion effect between charged electrode and solute(drug reservoir)Applied electric current of 0.5mA/cm2
Low M.W (‹500 Da)Ex- Lidocaine, metoclopramide plus hydrocortisone, vincristine etc,.
Contd...
05/01/23SAGAR KISHOR SAVALE54
2. Electroporation:-
Process involves the application of large transmembrane voltages caused by electrical pulses (10μs–100ms).It cause formation of transient pores in the membrane that allow the passage for drug.Induce steady-state transport through skin with in minute.Controllable through manipulation of electrical pulse.
Contd...
05/01/23SAGAR KISHOR SAVALE55
3. Ultrasound (or sonophoresis):-
Traditionally associated with physiotherapy, sports medicine and medical imaging than TDDs.It produces physical air pressure above topical skin.Deliver drug in low frequency range 20 kHz. (less than used in physiotherapy 1MHz)
Contd...
05/01/23SAGAR KISHOR SAVALE56
4. Photochemical Waves:-
It also known as laser generated stress wavesPWs are the pressure pulses produced by ablation of a material target.It is not much more attention.
5. Laser Ablation:-
The use of lasers to remove the stratum corneum barrier by controlled ablation.It is reported that use of LAs on pig Stratum corneum- hydrocortisone.
6. Combination of electrically based physical enhancement technique and chemical enhancers.
Contd...
05/01/23SAGAR KISHOR SAVALE57
Structured- based technique:-
Microneedle:-
They create a physical pathway through the upper epidermis to increase skin permeability.Made up of siliconSilicon needles individual measuring about 150μm in length and 80μm base diameter and fabricated on array of 3x3 mm (400 needles).
Contd...
05/01/23SAGAR KISHOR SAVALE58
Velocity based technique-
Jet-propelled particles:-
It propel the drug into the skin.High velocity jet (100m/s) of compressed gas (helium).
05/01/23SAGAR KISHOR SAVALE59
05/01/23SAGAR KISHOR SAVALE60
Absorbed in Surface of sebum
Transdermal
Trans follicular
Intracellular Pathway Intercellular Pathway
Stratum Corneum
Pilosebaceous Unit Eccrine Gland
Sebaceous GlandHair Follicles
Dermis
Microcirculation
Viable Epidermis
Percutaneous absorptionDrug can releases from dosage from
05/01/23SAGAR KISHOR SAVALE61
05/01/23SAGAR KISHOR SAVALE62
Generally, drug absorption into the skin occurs by passive diffusion.
The rate of drug transport across the stratum corneum follows fick’s first law of diffusion.
dm/dt = J = d a k/h Where,
dm / dt = J = rate of diffusion / study state flux.d = diffusion coefficient.a = surface area of membrane.k = partial coefficient between the stratum corneum and the vehicle.h = diffusional path length / membrane thickness.
05/01/23SAGAR KISHOR SAVALE63
In other words, the rate of drug transport depends not only on its aqueous solubility,
But is also directly proportional to its oil/water partition coefficient, its concentration in the formulation vehicle, and the surface area of the skin to which it is exposed;
It is inversely proportional to the thickness of the stratum corneum.
05/01/23SAGAR KISHOR SAVALE64
D] Approaches Used in TDDs:-Approache
s
A) According to drug release mechanisms:-1. Matrix-diffusion controlled TDDS’s2. Membrane-permeation controlled TDDS’s3. Microreservoir type or Micro sealed dissolution controlled TDDS’s4. Adhesive dispersion type TDDS’s
B) According to rate controlling step:-1. Those control the rate of drug delivery to skin.2. Those allow the skin to control the rate of drug absorption.
C) According to polymer:-1. Hydrophilic or hydro gel system2. Hydrophobic or occlusion system
Contd...
05/01/23SAGAR KISHOR SAVALE65
a] According to drug release mechanisms:-
1. Matrix-diffusion controlled TDDS’s:- Drug Reservoir- Dispersing drug particles in a
hydrophilic or lipophilic polymer matrix which is accomplished by:
Homogeneously mixing of grounded particlesLiquid
polymer
Highly viscous base polymer
Blending of particle with rubbery polymer
Molded in medicated discAlso by dissolving Drug and Polymer in common
solvent solvent evaporation method
Pasted on occlusive base plate
Impermeable plastic membrane
Contd...
05/01/23SAGAR KISHOR SAVALE66
Example:- Nitroglycerin-releasing transdermal therapeutic system (Nitro-Dur ) for therapy of angina pectoris at a daily dose of 5mg/cm2.
Contd...
05/01/23SAGAR KISHOR SAVALE67
2. Membrane-permeation controlled TDDS’s:-Drug reservoir- Grounded Drug particles
Dispersed in solid polymer matrix
Suspended in viscous liquid medium (silicon)
Rate-controlling polymeric membrane (EVA)
Adhesive polymer (silicon, PA)
The release of Drug from the system by rate- controlling polymer.Achieved by Polymer composition, permeability coefficient and thickness.
Contd...
05/01/23SAGAR KISHOR SAVALE68
Examples:-•Nitroglycerine –releasing transdermal system (once a day for angina pectoris)•Scopolamine-releasing transdermal system (72hrs for motion sickness)•Clonidine-releasing transdermal system (7 days for hypertension)
The constant release of the drug is the major advantages of these approaches.
Contd...
05/01/23SAGAR KISHOR SAVALE69
3. Microreservoir type or Micro sealed dissolution controlled TDDS’s:-It can be considered as a combination of the reservoir and matrix diffusion type drug delivery systems.Drug reservoir:- Drug particle
Drug suspension
Dispersing in a lipophilic polymer (silicon) by high dispersion technique
Spheres of DRMedicated disc
Surrounded by adhesive film
Aqueous solution (water-soluble liq. Polymer)
Contd...
05/01/23SAGAR KISHOR SAVALE70
Example- Nitrodisc for angina pectoris (0.5mg/cm2 OD)The release of drug from this system can follow either a partition control or matrix diffusion-control process.
Contd...
05/01/23SAGAR KISHOR SAVALE71
4. Adhesive dispersion type TDDS’s:-
Simple form of Membrane-permeation controlled TDDs.
Drug reservoir:- Drug particleDispersed in adhesive polymer (poly (isobutylene) or poly(acrylate) )
Medicated disc (solvent casting or hot melt)Impermeable film
Example-Isosorbide dinitrate,releasing TDDs for angina pectoris (OD)
Contd...
05/01/23SAGAR KISHOR SAVALE72
b] According to rate controlling step:-
Those they control the rate of drug delivery to the skin. Potent, for maintaining MEC
Those that allow the skin to control the rate of drug absorption.
Having wide range of plasma drug concentration.c] According to polymer:-
Hydrophilic or hydro gel system:-Drug release by swelling mechanism.Patch of these type absorb water from the skin.Causes skin irritation & burning sensation.
Contd...
05/01/23SAGAR KISHOR SAVALE73
Hydrophobic or occlusion system:-
Prevent losing of water from the skin.Swelling of Horny layer at skin surface.Increases the temperature and resulting in increase in molecular motion & skin permeation & decrease in protein network density.Causes sweat retention syndrome, irritation reaction.
05/01/23SAGAR KISHOR SAVALE74
Production of TDDS’s:-There are 3 main steps in production of TDDS’s:-
Contd...
05/01/23SAGAR KISHOR SAVALE75
General Scheme for Production :-
05/01/23SAGAR KISHOR SAVALE76
Outline of Production of TDDS’s:-
05/01/23SAGAR KISHOR SAVALE77
E] Model Drug Selection Criteria:-Most drugs are not suitable candidate for Transdermal drug delivery for one or more reason-
‘Easy to deliver’ drugs have already been commercialized into TDDs.To date 10 drugs out of 100 have been commercialized into TDDs.More than 35 patches spanning 13 molecules present in market.
For successfully developing a transdermal drug delivery system, the drug should be chosen with great care. The drug possesses the right mix of physicochemical and biological properties for transdermal drug delivery.
Contd...
05/01/23SAGAR KISHOR SAVALE78
The following are some desirable properties of a drug for Selection of drug for transdermal delivery:-
Biological Properties:-Therapeutic Index:- Narrow therapeutic indexFirst-pass metabolism- drug which goes extensive to First-pass metabolism.Biological Half Life- Short (10hrs or less)Skin Toxicity- Should not irritant and sensitizing to skin.Dose- less than 20mg/day.Immunogenicity- Drug should not stimulate on immune reaction.
Contd...
05/01/23SAGAR KISHOR SAVALE79
Physicochemical Properties:-Molecular Weight:- less than 500 Daltons.Partition coefficient- Should have octanol-water partition coefficient (LogP) value in range 1.0- 4.0 .Drug StabilitySkin permeability coefficient- greater than 0.5x10 cm/hr.Melting point- low (2000 F).
05/01/23SAGAR KISHOR SAVALE80
05/01/23SAGAR KISHOR SAVALE81
05/01/23SAGAR KISHOR SAVALE82
05/01/23SAGAR KISHOR SAVALE83
05/01/23SAGAR KISHOR SAVALE84
05/01/23SAGAR KISHOR SAVALE85
Sr. No.
Evaluation Parameters
1 Percentage of Moisture Absorption
2 Percentage of Moisture Loss3 Thickness of Film4 Weight Variation5 Drug Content6 In vitro drug release study7 In vivo drug release study8 Stability test9 Sterility test10 Tensile strength11 Water Absorption test
05/01/23SAGAR KISHOR SAVALE86
Physicochemical Evaluation of Transdermal Patches Thickness - travelling microscope, dial/screw gauge,
micrometer
Weight variation – weigh 10 patches
Drug content – by suitable validated analytical method
Folding endurance – repeatedly folding at same point until it break . The number of times it could be folded is its folding endurance value.
05/01/23SAGAR KISHOR SAVALE87
Content uniformity- 10 patches are selected and content is determined for individual patches. If 9 out of 10 patches have content between 85% to 115% of the specified value and one has content not less than 75% to 125% of the specified value, then Transdermal patches pass the test of content uniformity. But if 3 patches have content in the range of 75% to 125%, then additional 20 patches are tested for drug content. If these 20 patches have range from 85% to 115%, then the Transdermal patches pass the test.
Microscopic study- SEM
05/01/23SAGAR KISHOR SAVALE88
•Microscopic study- SEM
88
Microscopic view of gestodene TDDS
05/01/23SAGAR KISHOR SAVALE89
Swellability-The degree of swelling (% S) was calculated using the formula
S (%) = Wt – Wo/Wo x 100Where S is percent swelling Wt is the weight of patch at time t and W o is
the weight of patch at time zeroSurface pH-Hardness-Physical appearance
All the Transdermal patches were visually inspected for color, clarity, flexibility, and smoothness
05/01/23SAGAR KISHOR SAVALE90
Flatness one strip is cut from the centre and two from each side of patches. The length of each strip is measured and variation in length is measured by determining percent constriction. Zero percent constriction is equivalent to 100 percent flatness.
% constriction =[(I1-I2)/I1]X100 I2 = Final length of each strip I1 = Initial length of each strip Percentage of moisture content % Moisture content = Initial weight – Final weight X
100 Final weight
05/01/23SAGAR KISHOR SAVALE91
Percentage of moisture uptake-
% moisture uptake = Final weight – Initial weight X 100 Initial weight Water Vapor Transmission study- WVT = W/ ST W is the increase in weight in 24 h; S is area of
film exposed (cm2); T is exposure time .Tensile strength- Tensile strength= F/a.b (1+L/l) F is the force required to break; a is width of film; b is
thickness of film; L is length of film; l is elongation of film at break point
05/01/23SAGAR KISHOR SAVALE92
Peel Adhesion properties Tack properties
I. Thumb tack testII. Rolling ball testIII. Quick stick (Peel tack) testIV. Probe tack test
Shear Strength
05/01/23SAGAR KISHOR SAVALE93Figure: 1 Peel Adhesion Test
In this test, the force required to remove an adhesive coating form a test substrate is referred to as peel adhesion.
Molecular weight of adhesive polymer, the type and amount of additives are the variables that determined the peel adhesion properties.
A single tape is applied to a stainless steel plate or a backing membrane of choice and then tape is pulled from the substrate at a 180°C angle, and the force required for tape removed is measured.
05/01/23SAGAR KISHOR SAVALE94
It is the ability of the polymer to adhere to substrate with little contact pressure. Tack is dependent on molecular weight and composition of polymer as well as on the use of tackifying resins in polymer
The force required to remove thumb from adhesive is a measure of tack.
This test measures the softness of a polymer.
05/01/23SAGAR KISHOR SAVALE95 Figure: 2 Rolling ball tack test
In this test, stainless steel ball of 7/16 inches in diameter is released on an inclined track so that, it rolls down and comes into contact with horizontal, upward facing adhesive (Figure: 2).
The distance the ball travels along the adhesive provides the measurement of tack, which is expressed in inch
05/01/23SAGAR KISHOR SAVALE96
Figure: 3 Quick stick (peel-tack) test
In this test, the tape is pulled away from the substrate at 90ºC at a speed of 12 inches/min. The peel force required breaking the bond between adhesive and substrate is measured (Figure-3) and recorded as tack value, which is expressed in ounces or grams per inch width .
05/01/23SAGAR KISHOR SAVALE97Figure: 4 Probe Tack test
In this test, the tip of a clean probe with a defined surface roughness is brought into contact with adhesive, and when a bond is formed between probe and adhesive. The subsequent removal of the probe mechanically breaks it (Figure-4). The force required to pull the probe away from the adhesive at fixed rate is recorded as tack and it is expressed in grams.
05/01/23SAGAR KISHOR SAVALE98 Figure: 5 Shear strength properties
Shear strength is the measurement of the cohesive strength of an adhesive polymer i.e. device should not slip on application determined by measuring the time it takes to pull an adhesive coated tape off a stainless plate.
05/01/23SAGAR KISHOR SAVALE99
05/01/23SAGAR KISHOR SAVALE100
05/01/23SAGAR KISHOR SAVALE101
Comparison in In vitro and In vivo Transdermal permeation rates
Permeation rates (mcg/cm2/day) In vitro In vivo
Drugs Delivery systems
Hairless mouse
Human cadaver
Nitroglycerin
Nitro disc 435.6 - 713.0
Nitro dur 400.1 487.9 411.6Transderm- nitro
349.2 461.5 427.9
Deponit 269.5 - 282.5
Estradiol Estraderm 9.6 6.5 5.0Clonidine Catapres-
TTS68.9 49.2 38.9
05/01/23SAGAR KISHOR SAVALE102
According to the International Conference on
Harmonization (ICH) guidelines by storing the TDDS
samples at 40± 2°C and 75 ± 5% RH for 6 months.
The samples were withdrawn at 0, 30, 60, 90 and
180 days and analyzed for drug content by suitable
analytical technique.
05/01/23SAGAR KISHOR SAVALE103
Toxicological Evaluation-a) Contact dermatitis 1. contact irritant dermatitis 2. ten day primary irritation test 3. twenty one day irritation test 4. laser doppler 5. evaporative water loss measurement 6. contact allergic dermatitis b) Growth of microorganisms 1. localized superficial infections 2. miliaria(prickly heat)
05/01/23SAGAR KISHOR SAVALE104
REGULATORY STRATEGY FOR INVESTIGATIONAL NEW DRUG (IND) APPLICATION AND NEW DRUG APPLICATION SUBMISSIONS FOR TDDS
Standard irritation and sensitization studies should be performed with the patch itself in
animals/humans. Negotiate the timing and implementation of the toxicology requirements. The dermatology division at FDA should review dermal aspects of the IND and New drug
Application(NDA). Primary review should occur at the division that handles the indication under study. Dose ranging studies be required in Phase 2. Single Phase 3 study could be negotiated.
05/01/23SAGAR KISHOR SAVALE105
Drug Trade name Type of
transdermal patch
Manufacturer Indication
Fentanyl Duragesic Reservoir Alza / Janssen Pharmaceuticals Analgesic
Nitroglycerine
Deponit
Minitran
Nitro disc
Nitro- dur
Transderm-Nitro
Drug in adhesive
Drug in adhesive
Micro reservoir
Matrix
Reservoir
Schwarz Pharma
3M Pharmaceuticals
Searle, USA
Key Pharmaceuticals
Alza/Novartis
Angina Pectoris
Scopolamine Transderm- Scop Membrane matrix hybrid type Alza/Novartis Motion sickness
References:-Chein, Y W, 1992, Novel Drug Delivery System, 2nd edition, vol-14, Marcel Dekker Inc, New York, pp- 301-314.Banker, G S, & Rhodes, C T, 2002, Modern Pharmaceutics, 4th edition, vol-121, Marcel Dekker Inc, New York, pp. 187-192.Hsieh, D S, 1994, Drug Permeation Enhancement, theory and
application, vol-62, Marcel Dekker Inc, New York, pp. 3-23.Roberts, M S, & Walters, K A, 1998, Dermal Absorption and
Toxicity Assessment, vol-91, Marcel Dekker Inc, New York, pp 297-309 371-375.Walters, K A, 2002, Dermatological and Transdermal
Formulation,vol-119, Marcel Dekker Inc, New York, pp 1-14 337-339.Brahmankar, D M & Jaiswal, S B, 2005, Biopharmaceutics and
Pharmacokinetics A Treatise, Vallabh prakashan, Delhi, pp-365-369.
05/01/23SAGAR KISHOR SAVALE106
Sachan, N.K, et al, 2009, Transdermal Approaches in drug delivery, Der Pharmacia Lettre, pp 4-47.Heather, A E, 2005, Transdermal Drug Delivery: Penetration Enhancement Techniques, Current Drug delivery, vol-2, pp 23-33.Kandavilli, S, et al, 2002, Polymers used in Transdermal Drug delivery System, Pharmaceutical Technologies, pp 62-80.Pathan, B I, et al, 2009, Chemical Penetration Enhancers for Transdermal Drug delivery System, Tropical Journal of
Pharmaceutical Research, pp 173-179.Cross, S E, et al, 2004, Physical Enhancement of Transdermal Drug Application: Is Delivery Technology Keeping up with Pharmaceutical Development?, Current Drug Delivery, pp 81-92.Aggarwal, G, 2009, Development, Fabrication and Evaluation of Transdermal Drug Delivery System - A Review, Pharmainfo, Vol. 7 Issue 5.
05/01/23SAGAR KISHOR SAVALE107